SCHEMBL2309

SCHEMBL2309

CC(O)[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3128037 1.00
SCHEMBL17960005 0.95
SCHEMBL28622396 0.76 ALDH1A1 (0.42)
SCHEMBL27704194 0.73
Isopropyl Alcohol SCHEMBL27705768 0.72 ALDH1A1 (0.86)
Isopropyl Alcohol SCHEMBL27594181 0.72
SCHEMBL18860475 0.70
SCHEMBL28282591 0.70
SCHEMBL3088281 0.70
SCHEMBL1364768 0.70 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1058 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085078-A1 NON-AQUEOUS SYNTHESIS OF SILYLCARBONATE SOLVENTS UCHICAGO ARGONNE, LLC (US) 2026-03-26 US claimed
CN-119588427-A MOF-based composite material, and method and application for detecting VC by catalytic oxidation of TMB 洛兮生命科技(杭州)有限公司 2025-03-11 CN claimed
CN-118165193-A Concrete additive and preparation method and application thereof 湖南科之杰新材料有限公司 2024-06-11 CN claimed
US-20240139120-A1 TREATING DISEASE AND PROMOTING WEIGHT LOSS BY INHIBITING THE TMA/FMO3/TMAO PATHWAY THE CLEVELAND CLINIC FOUNDATION 2024-05-02 US claimed
CN-117402372-A Preparation method of medium-temperature curing flame-retardant lignin-based curing agent 上海汉禾生物新材料科技有限公司 2024-01-16 CN claimed
CN-117343282-A Preparation method and application of flame-retardant lignin-based epoxy resin 上海汉禾生物新材料科技有限公司 2024-01-05 CN claimed
EP-4299064-A2 TREATING DISEASE AND PROMOTING WEIGHT LOSS BY INHIBITING THE TMA/FMO3/TMAO PATHWAY THE CLEVELAND CLINIC FOUNDATION (US) 2024-01-03 EP claimed
US-11771659-B2 Treating disease and promoting weight loss by inhibiting the TMA/FMO3/TMAO pathway THE CLEVELAND CLINIC FOUNDATION (US) 2023-10-03 US claimed
CN-115894809-A Core-shell emulsion, preparation method and application 绵阳华远同创科技有限公司 2023-04-04 CN claimed
CN-115385867-A Cyclization reaction and ring opening method of amino acid and analogue thereof 安徽普利药业有限公司 2022-11-25 CN claimed
WO-2001030734-A1 NOVEL HYDRONAPHTALENE COMPOUNDS, PREPARED BY A RHODIUM CATALYZED RING OPENING REACTION IN THE PRESENCE OF PHOSPHINE LIGAND ASTRAZENECA AB (SE) 2001-05-03 WO claimed
EP-0483162-B1 SEQUENTIAL C-TERMINAL DEGRADATION OF PEPTIDES AND PROTEINS HOPE CITY (US) 1997-03-26 EP claimed
EP-0495939-B1 SEQUENTIAL C-TERMINAL DEGRADATION OF PEPTIDES AND PROTEINS HOPE CITY (US) 1996-11-27 EP claimed
EP-0483162-A4 SEQUENTIAL C-TERMINAL DEGRADATION OF PEPTIDES AND PROTEINS 1993-01-07 EP claimed
EP-0495939-A4 SEQUENTIAL C-TERMINAL DEGRADATION OF PEPTIDES AND PROTEINS 1992-11-25 EP claimed
EP-0495939-A1 SEQUENTIAL C-TERMINAL DEGRADATION OF PEPTIDES AND PROTEINS. HOPE CITY (US) 1992-07-29 EP claimed
EP-0483162-A1 SEQUENTIAL C-TERMINAL DEGRADATION OF PEPTIDES AND PROTEINS. HOPE CITY (US) 1992-05-06 EP claimed
WO-1992003737-A1 SEQUENTIAL C-TERMINAL DEGRADATION OF PEPTIDES AND PROTEINS CITY OF HOPE (US) 1992-03-05 WO claimed
WO-1991018008-A1 SEQUENTIAL C-TERMINAL DEGRADATION OF PEPTIDES AND PROTEINS CITY OF HOPE (US) 1991-11-28 WO claimed
US-5059540-A Coupling the peptide with a silane isothiocyanate to form a thiohydantoin derivative CITY OF HOPE (US) 1991-10-22 US claimed